Acushnet full-year 2024 net sales rise 3.2% to $2.46 billion; sets 2025 outlook
Acushnet reported full-year 2024 net sales of $2.46 billion, up 3.2%, and net income attributable to the company of $214.3 million, up $15.9 million, with fourth-quarter net loss narrowing to $1.1 million from $26.8 million a year earlier. The company also gave a 2025 outlook of $2.49 billion to $2.54 billion in net sales and $405 million to $420 million in Adjusted EBITDA, and raised its quarterly dividend 9.3% and added a $250.0 million share repurchase authorization.
Key points
- Full-year 2024 Adjusted EBITDA was $404.4 million, up 7.5%, and fourth-quarter Adjusted EBITDA was $12.4 million versus a $1.5 million loss a year earlier
- 2025 outlook calls for net sales of $2,485 million to $2,535 million and Adjusted EBITDA of $405 million to $420 million, including an estimated negative currency impact of about $35 million
- Quarterly cash dividend increased 9.3% to $0.235 per share, payable March 21, 2025 to holders of record as of March 7, 2025
- On February 13, 2025, the board authorized an additional $250.0 million in share repurchases, bringing the total authorization to $1.25 billion
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 7:02 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 27, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.